Interestingly, Galectin-9/TIM-3 expression is upregulated in patients failing chemotherapy [125], and is associated with central memory and memory stem T cell exhaustion in AML patients with disease relapse after HSCT [126]. This evidence concerns the gene LGALS9 and acute myeloid leukemia.